The primary purpose of the Transgenic/Knock-out Mouse Shared Resource is to provide an efficient andeconomical means for producing genetically modified mice for members of the Massey Cancer Center.Genetically modified mice (including transgenic mice, in which customized genes are introduced into thegenome, or 'knock-out/knock-in' mice, in which endogenous genes within the mouse genome arespecifically inactivated or modified) have become an indispensable tool in cancer research. The utility ofsuch models ranges from studies of the basic biology of tumorigenesis and progression to the creation ofgenetically accurate tumor models for the evaluation of novel therapeutic approaches. TheTransgenic/Knock-out Mouse Shared Resource offers the following services:Transgenic mouse production: The core generates at least three founder mice for each transgene.Knock-out/knock-in mouse production: The core can perform all or a subset of the followingprocedures: ES cell electroporation; ES cell culture under appropriate selection conditions; expansion ofdrug-resistant clones; PCR/Southern blot screening of clones for the correct recombination event; reelectroporationwith a ere expression vector to delete floxed selection markers and subsequent rescreeningof clones; injection of targeted ES cell clones into blastocysts for chimeric mouse production.For projects in which the core has performed the ES cell targeting, at least two independent ES cellclones are generally injected into blastocysts, and a minimum of five chimeras are generated.Mouse line rederivation: Lines of pathogen-infected mice are rederived by embryo transfer to generatespecific pathogen-free mice.Sperm cryopreservation: Lines of mice are cryopreserved by collection, freezing, and long-term liquidnitrogen storage of sperm. When needed, re-establishment of the line can be accomplished by thawingsperm and performing in vitro fertilization of eggs isolated from WT females.Tail DNA genotyping: The core isolates genomic DNA from tail biopsies (or other tissue) provided bythe investigator and performs PCR genotyping.Consulting services: The core provides consultation on many aspects of transgenic/knock-out mousetechnology, including experimental design, vector design, budgeting for mouse colony maintenance, andpreparation of applications to the IACUC for the use of laboratory animals in research. In addition, thecore staff provides instruction on overall colony management, including breeding strategies, weaning, earpunching, and tail DNA isolation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016059-28
Application #
7698823
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-03
Project End
2011-04-30
Budget Start
2008-09-03
Budget End
2009-04-30
Support Year
28
Fiscal Year
2008
Total Cost
$33,784
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Yamada, Akimitsu; Nagahashi, Masayuki; Aoyagi, Tomoyoshi et al. (2018) ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. Mol Cancer Res 16:1059-1070
Cantwell, Marc T; Farrar, Jared S; Lownik, Joseph C et al. (2018) STAT3 suppresses Wnt/?-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine 111:434-444
Aqbi, Hussein F; Wallace, Matthew; Sappal, Samay et al. (2018) IFN-? orchestrates tumor elimination, tumor dormancy, tumor escape, and progression. J Leukoc Biol :
Volker, Sonja E; Hedrick, Shannon E; Feeney, Yvonne B et al. (2018) Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland. Cancer Res 78:3877-3887
Li, Xiaojiaoyang; Liu, Runping; Huang, Zhiming et al. (2018) Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68:599-615
Durant, Stephen T; Zheng, Li; Wang, Yingchun et al. (2018) The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv 4:eaat1719
Damle, S R; Martin, R K; Cockburn, C L et al. (2018) ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Allergy 73:125-136
Wang, Feng; Li, Hongyan; Markovsky, Ela et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget 9:9311-9324
Stokes, Nancy A; Stanciu, Cristina E; Brocato, Emily R et al. (2018) Simplification of complex DNA profiles using front end cell separation and probabilistic modeling. Forensic Sci Int Genet 36:205-212
Poklepovic, Andrew; Qu, Yuesheng; Dickinson, Molly et al. (2018) Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardiooncology 4:

Showing the most recent 10 out of 586 publications